BioTechX USA
As life sciences, pharma, and healthcare teams lean more on AI, Patlytics is showing up to discuss what that means for the patents behind it.
Patlytics will be on the ground at BioTechX USA, taking in how pharma teams and researchers are using AI in diagnostics, data management, precision medicine, and more.
It's a chance to see firsthand what that shift means for how life science patents get filed, defended, and put to work.
Chemical structures and sequences, drafted natively
Draw chemical structures, define Markush groups, and draft from biological sequences directly in the workspace with FDA Orange Book and Purple Book data built in.
Freedom-to-operate before launch
Search and analysis across US, EP, KR, JP, WO, TW, and CN filings, backed by a 145M+ patent database and 300M+ NPL works.
Portfolio strategy, not just prosecution
Portfolio Heatmap and Patent Vault surface licensing and pruning opportunities across a company's patents, so IP findings can feed directly into licensing and M&A conversations.
Will you be at BioTechX USA?
Schedule a time to meet with us during the event.



